Sonnet BioTherapeutics Holdings, Inc. (SONN) analyst actions
Rating and price-target actions on SONN in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the SONN overview →
1 measured SONN analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Sonnet BioTherapeutics Enters into Clinical Collaboration Agreement to Commence Investigator-Initiated and Funded Phase 1/2a Study of SON-1210 in Combination with Chemotherapy for the Treatment of Pancreatic Cancer | Press release | +0.52% | +0.25% |
Keep exploring
More SONN: earnings → · SEC filings → · SONN overview →